Patient-Driven Values in Healthcare Evaluation (PAVE) is a Center of Excellence in Patient-Driven Value Assessment dedicated to promoting value-based decision-making through a diverse multi-stakeholder collaboration and engaging patients from an extensive network of partners to build technical expertise in patient-centered outcomes research, education, and dissemination.

Artwork for Patient-Driven Values in Healthcare EvaluationPAVE is funded by a grant from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation and strives to bring together patients and other stakeholders, including value framework developers and users, to co-produce reliable and meaningful value assessments to support patient-centered health care decision-making.

For a quick introduction to PAVE, including brief descriptions of our ongoing activities and information about our key staff, please download this one-page overview document.

The Patient Perspective Approach Should Guide Value Assessments of COVID-19 Vaccines

As the U.S. continues its mass rollout of the COVID-19 vaccine, key questions remain concerning how policymakers should value these treatments – and how we should measure societal benefits associated with getting vaccinated. It is crucial that these discussions prominently feature the patient voice.

Read the Full Article
PAVE: Understanding Patient Values in Treatments for Major Depressive Disorders

Watch this short video, which features an interview with Susan dosReis, PhD, professor in the Department of Practice, Sciences, and Health Outcomes Research (P-SHOR) and director of PAVE, to learn more about the program and its research on patient values in treatments for major depressive disorders.

New Infographic Highlights Value in Hepatitis C Virus Treatment

PAVE researchers outline a novel, more patient-centered methodology to assess Hepatitis C treatments in collaboration with a stakeholder advisory board that included several patients diagnosed with the disease.

View the Infographic

PAVE is a collaboration between the University of Maryland School of Pharmacy, the National Health Council, patient community leaders, and payer and industry stakeholders.

The program aims to:

  • Expand patient and other stakeholder engagement partnerships.
  • Educate the patient and research communities.
  • Support patient-driven value assessment research.
  • Disseminate patient-driven value assessment principles and methods.
Community and Patient Partnerships

PAVE could not accomplish its important work without the help of its patient and community partners. Learn more about these important partnerships and how you can get involved with our program.

Learn More